Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Shuteria involucrata* (Wall.) Wight & Arn., known as "Tong-qian-ma-huang" in Dai folk medicine, is a traditional medicinal plant native to southern China. It is primarily recognized for its efficacy in treating respiratory conditions, including allergic and obese asthma. The roots of the plant contain a variety of bioactive compounds, most notably the involucrasins (A, B, C, and D), renifolin F, and other flavonoids. These components exert potent anti-inflammatory effects by inhibiting the TLR4/NF-κB and NLRP3 inflammasome signaling pathways, thereby reducing the secretion of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α. Furthermore, research has demonstrated that involucrasin A possesses anticancer properties against colorectal cancer cells by modulating the Akt/MDM2/p53 pathway, leading to apoptosis and inhibition of cell proliferation. While currently in the preclinical research stage, *S. involucrata* represents a significant source of natural lead compounds for inflammatory and oncological therapeutic development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shuteria involucrata.